Corcept Therapeutics, Inc. (CORT)
72.96
-0.75
(-1.02%)
USD |
NASDAQ |
Nov 13, 16:00
72.96
0.00 (0.00%)
After-Hours: 19:59
Corcept Therapeutics Shareholders Equity (Quarterly) : 833.74M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 833.74M |
| June 30, 2026 | 705.78M |
| March 31, 2026 | 637.99M |
| December 31, 2025 | 647.80M |
| September 30, 2025 | 631.90M |
| June 30, 2025 | 635.79M |
| March 31, 2025 | 683.28M |
| December 31, 2024 | 679.59M |
| September 30, 2024 | 638.84M |
| June 30, 2024 | 596.24M |
| March 31, 2024 | 547.86M |
| December 31, 2023 | 506.70M |
| September 30, 2023 | 461.68M |
| June 30, 2023 | 421.61M |
| March 31, 2023 | 529.58M |
| December 31, 2022 | 501.84M |
| September 30, 2022 | 473.36M |
| June 30, 2022 | 442.33M |
| March 31, 2022 | 407.81M |
| December 31, 2021 | 375.81M |
| September 30, 2021 | 540.23M |
| June 30, 2021 | 522.68M |
| March 31, 2021 | 510.80M |
| December 31, 2020 | 523.34M |
| September 30, 2020 | 489.68M |
| Date | Value |
|---|---|
| June 30, 2020 | 453.70M |
| March 31, 2020 | 409.49M |
| December 31, 2019 | 371.18M |
| September 30, 2019 | 334.38M |
| June 30, 2019 | 298.05M |
| March 31, 2019 | 285.76M |
| December 31, 2018 | 275.88M |
| September 30, 2018 | 259.54M |
| June 30, 2018 | 243.51M |
| March 31, 2018 | 215.23M |
| December 31, 2017 | 190.97M |
| September 30, 2017 | 86.30M |
| June 30, 2017 | 66.14M |
| March 31, 2017 | 49.58M |
| December 31, 2016 | 41.38M |
| September 30, 2016 | 31.25M |
| June 30, 2016 | 25.66M |
| March 31, 2016 | 20.17M |
| December 31, 2015 | 18.50M |
| September 30, 2015 | 13.48M |
| June 30, 2015 | 11.53M |
| March 31, 2015 | 10.57M |
| December 31, 2014 | -3.388M |
| September 30, 2014 | -1.317M |
| June 30, 2014 | 3.452M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 89.00B |
| Phibro Animal Health Corp. | 417.67M |
| Illumina, Inc. | 3.145B |
| Eli Lilly & Co. | 40.27B |
| Merck & Co., Inc. | 44.89B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.034B |
| Total Liabilities (Quarterly) | 200.29M |
| Debt to Equity Ratio | 0.0108 |
| Current Ratio | 2.971 |
| Net Debt Paydown Yield | 0.00% |